Highlights of Past EHA (HOPE) EMEA 2020

EHA is excited to announce the 5th edition of the Highlights of Past EHA (HOPE) Europe, Middle East & Africa (EMEA) in Istanbul, Turkey. The meeting is organized in partnership with regional and national societies in Europe (Balkan), the Middle East and Africa.

Dates: September 17-19, 2020TSH Logo en
Location: Istanbul, Turkey

Prof John Gribben, President, European Hematology Association (EHA)
Prof Hayri Özsan, President, Turkish Society of Hematology (TSH)

HOPE EMEA 2020 aims to bring the key messages from various fields of hematology of the 25th Congress of EHA to neighboring European countries (Balkan), the Middle East and Africa (EMEA).

Online registration will open soon

Below you can find key information and links to important details regarding registration and accommodation. There is also a wide array of sponsorship opportunities available for pharmaceutical companies.

Meeting objectives

Participants of HOPE EMEA 2020 will be able to:

  • enhance their knowledge of evidence-based approaches on diagnosis and treatment for hematologic diseases,
  • access the latest results on clinical and translational research in hematologic disorders,
  • be updated on emerging innovative techniques, diagnostic tools and risk-assessment strategies in hematology and its subspecialties, and
  • communicate, collaborate and network with colleagues and representatives of a large international audience from the medical industry.


The HOPE EMEA 2020 program covers a variety of topics from the 25th Congress of EHA by key leaders in their fields.

Please find below an overview of the topics covered in the program:

  • Acute leukemias
  • Benign hematology
  • Lymphoproliferative disorders
  • Myelodysplastic syndromes
  • Myeloproliferative neoplasms
  • Pediatric hematology
  • Plasma cell disorders

For the full meeting program, click here.

Abstract submission

The abstract program will allow researchers and clinicians from the region to profile the work and share it with an audience of their peers.

Abstract submission has officially opened. For more information and to submit your abstract, click here.

Target audience

Physicians, clinicians, basic researchers, biologists, trainees, medical students and pharmaceutical companies in neighboring European countries (Balkan), the Middle East & Africa interested in the broad field of hematology, specifically those who could not attend the 25th Congress of EHA.


The meeting venue will be announced shortly.

Key dates


Online registration for HOPE EMEA 2020 will open soon.

EBAH CME Accreditation

EBAH accredited stamp DEF2Highlights of Past EHA (HOPE) meetings are accredited by the European Board for Accreditation in Hematology (EBAH) CME. EBAH CME is the best way for hematologists to master the latest developments within the specialty of hematology. Staying abreast of these scientific developments and keeping in touch with up-to-date views on clinical policy will enable you to raise your professional level, resulting in the best treatment for your patients.